Medical Supplierz Expands Global Access to Leading Medical Manufacturers
KUWAIT, KUWAIT, July 7, 2025 / EINPresswire.com / -- Medical Supplierz, a digital B2B procurement platform, has launched new initiatives to strengthen global connectivity between verified healthcare buyers and trusted medical manufacturers. The platform now serves as a centralized access point for hospitals, clinics, and healthcare institutions seeking high-quality medical equipment from vetted suppliers worldwide.
The expansion addresses a growing demand for reliable sourcing channels in the healthcare industry. As medical systems face mounting pressure to equip their facilities quickly and efficiently, many buyers are turning to digital solutions to access a broader supplier network. Medical Supplierz helps bridge this gap by offering a marketplace built exclusively for healthcare procurement.
Through the platform, buyers can explore product catalogs from a wide range of manufacturers and submit direct inquiries without relying on third-party intermediaries. This approach simplifies the procurement process, shortens negotiation cycles, and reduces associated costs. Buyers also benefit from access to verified manufacturer profiles, enabling informed purchasing decisions based on compliance standards, certifications, and product data.
For manufacturers, the platform opens doors to global markets that were previously difficult to enter due to regulatory and logistical barriers. Medical Supplierz facilitates cross-border trade by supporting transparency, language compatibility, and documentation verification. This environment allows manufacturers to build trust with procurement teams across multiple regions.
The platform's features include searchable product listings, region-specific demand insights, and tools for managing communications between buyers and suppliers. These functions contribute to faster response times and more efficient sourcing, especially for healthcare institutions in need of timely medical equipment access.
With buyers from over 40 countries already active on the platform, Medical Supplierz continues to scale its efforts to connect demand with supply across continents. By offering a secure, transparent, and healthcare-focused ecosystem, the platform supports improved procurement practices and strengthens resilience in medical supply chains.
About Medical Supplierz:
Medical Supplierz is a B2B digital platform designed to streamline procurement in the healthcare industry. By connecting verified buyers with top medical manufacturers, the platform provides a secure and efficient environment for global medical equipment trade.
Homod Falah Alshemmri
Medical Supplierz
+965 9408 9218
email us here
Visit us on social media:
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Adtalem Global Education Announces Fourth Quarter and Fiscal Year 2025 Conference Call
CHICAGO, July 07, 2025--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, announced today it will release its fourth quarter and fiscal year 2025 results on Thursday, Aug. 7, 2025, after financial markets close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results. The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Adtalem earnings call" or by using conference ID: 13754556. The call will be simulcast through the Adtalem investor relations website at: Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13754556, or visit the Adtalem investor relations website. About Adtalem Global Education Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a practice-ready workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and access is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 350,000 alumni and nearly 10,000 dedicated employees. Visit for more information and follow us on LinkedIn, Instagram and Facebook. View source version on Contacts Investor Contact Jay +1 312-906-6600 Media Contact Jason CarrAdtalemMedia@ +1 773-858-7932 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Here's What Boosted Tempus AI (TEM) in Q1
Frontier Capital Management, an investment management company, released its 'Frontier Small Cap Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. Class N shares of the fund returned -14.43% in the first quarter, compared to -11.12% for the benchmark Russell 2000 Growth Index. The fund returned -14.50% for the 12 months ended March 31, 2025, compared to the benchmark return of -4.86%. US equities traded lower in the first quarter, mainly during the last week of the quarter. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first quarter 2025 investor letter, Frontier Small Cap Growth Fund highlighted stocks such as Tempus AI, Inc. (NASDAQ:TEM). Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company. The one-month return of Tempus AI, Inc. (NASDAQ:TEM) was -1.77%, and its shares gained 97.44% of their value over the last 52 weeks. On July 3, 2025, Tempus AI, Inc. (NASDAQ:TEM) stock closed at $60.99 per share, with a market capitalization of $10.558 billion. Frontier Small Cap Growth Fund stated the following regarding Tempus AI, Inc. (NASDAQ:TEM) in its first quarter 2025 investor letter: "Our best contributing stock was Tempus AI, gaining 43% on the back of robust growth and the end of its initial public offering (IPO) lockup period. Tempus AI, Inc. (NASDAQ:TEM) is a health care company that combines its next generation diagnostics platform across multiple diseases with its leading data and analytics capabilities. Tempus is rooted in clinical care delivery as one of the largest sequencers of cancer patients and patients with other diseases. The company is building an intelligent diagnostics platform through the application of its artificial intelligence (AI) capabilities to allow physicians to deliver more personalized and data-driven therapies to patients and to help researchers develop more precise therapies. The Tempus platform collects numerous data types, and unlike peers, the data comes not only from its own labs but also from a variety of sources including more than 2,000 health care institutions and more than half of the practicing U.S. oncologists. Today, Tempus has a multimodal, de-identified database that is much larger than any other company or institution. This database creates a substantial economic moat and additional revenue stream for the company when it licenses the data to pharma companies to aid in therapy development. The company's recent rapid growth has been driven both by increased testing volumes, higher realized average selling prices, as more payors are covering their tests, and improved coverage and price through Medicare. While not yet profitable, Tempus guided slightly positive Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for 2025, a meaningful improvement compared to 2024 and prior periods." A doctor administering a diagnostic test kit for the detection of gastrointestinal diseases. Tempus AI, Inc. (NASDAQ:TEM) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held Tempus AI, Inc. (NASDAQ:TEM) at the end of the first quarter, compared to 17 in the previous quarter. In the first quarter of 2025, Tempus AI, Inc.'s (NASDAQ:TEM) revenue increased 75.4% year-over-year to $255.7 million. While we acknowledge the potential of Tempus AI, Inc. (NASDAQ:TEM) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Tempus AI, Inc. (NASDAQ:TEM) and shared the list of top healthcare AI stocks to buy according to hedge funds. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of TEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
39 minutes ago
- Yahoo
OPEC+ Agrees on Larger-Than-Expected Supply Hike Again
The Organization of the Petroleum Exporting Countries and its allies agreed Saturday to boost output again next month by more than expected, raising concerns about a potential oversupply. Oil prices fell initially but steadied later in the day. OPEC+, a grouping led by Saudi Arabia and Russia, agreed Saturday to add 548,000 barrels a day in August over July Organization of the Petroleum Exporting Countries and its allies (OPEC+) agreed Saturday to boost output again next month by more than expected, raising concerns about a potential oversupply. Oil prices steadied after falling on the news initially. Brent crude futures rose 0.6% to $68.69 per barrel, while West Texas Intermediate futures were little changed at about $66.98. OPEC+, a grouping led by Saudi Arabia and Russia, agreed to add 548,000 barrels a day in August over July levels, citing 'a steady global economic outlook and current healthy market fundamentals, as reflected in the low oil inventories' and its plans to end a voluntary output cut it started two years ago to prop up oil prices. The grouping had announced hikes of 411,000 barrels a day previously. 'Larger supply hikes increase the scale of the surplus in the oil market later in the year,' ING analysts said, pointing to the larger-than-expected increase in output. 'This supports the view that there's further downside for oil prices.' In early March, the group affirmed plans to gradually increase crude production beginning in April. The group had a policy of voluntary production cuts of 2.2 million barrels per day (B/D). Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
